Expiration date: 05/2026

Action: 

hypoglycemic agent

Composition:

gliclazide 30,0 mg

Excipients: hypromellose 70,0 mg, cellulose microcrystalline 98,0 mg, silicon colloidal dioxide of 1.0 mg magnesium stearate 1.0 mg

Indications:

diabetes type 2 the lack of effectiveness of diet, physical activity and reducing body mass

prevention of complications of diabetes: reducing the risk of microvascular and macrovascular complications in patients with diabetes type 2 diabetes through intensive glycemic control